InsidersTradesSigma
Browse the full record of transactions filed by Pivotal bioVenture Partners Fund I, L.P.. Insider active across 1 company, notably Inozyme Pharma, Inc.. In total, 1 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €3.7m. Activity tracked since 19 April 2022. The latest transaction was filed on 19 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条